Population Pharmacokinetics of Bedaquiline and Metabolite M2 in Patients With Drug‐Resistant Tuberculosis: The Effect of Time‐Varying Weight and Albumin

le Svensson, EM, Dosne, A‐G, Karlsson, MO
Foilsithe in CPT Pharmacometrics Syst Pharmacol (2016)

Implications for Drug Characterization in Glucose Tolerance Tests Without Insulin: Simulation Study of Power and Predictions Using Model‐Based Analysis

le Sheikh Ghadzi, SM, Karlsson, MO, Kjellsson, MC
Foilsithe in CPT Pharmacometrics Syst Pharmacol (2017)

Weight‐HbA1c‐insulin‐glucose model for describing disease progression of type 2 diabetes

le Choy, S, Kjellsson, MC, Karlsson, MO, de Winter, W
Foilsithe in CPT Pharmacometrics Syst Pharmacol (2015)

PK‐PD modeling of individual lesion FDG‐PET response to predict overall survival in patients with sunitinib‐treated gastrointestinal stromal tumor

le Schindler, E, Amantea, MA, Karlsson, MO, Friberg, LE
Foilsithe in CPT Pharmacometrics Syst Pharmacol (2016)

A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients

le Schindler, E, Amantea, MA, Karlsson, MO, Friberg, LE
Foilsithe in CPT Pharmacometrics Syst Pharmacol (2017)

Item Response Theory to Quantify Longitudinal Placebo and Paliperidone Effects on PANSS Scores in Schizophrenia

le Krekels, EHJ, Novakovic, AM, Vermeulen, AM, Friberg, LE, Karlsson, MO
Foilsithe in CPT Pharmacometrics Syst Pharmacol (2017)

Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches

le Møller, JB, Kristensen, NR, Klim, S, Karlsson, MO, Ingwersen, SH, Kjellsson, MC
Foilsithe in CPT Pharmacometrics Syst Pharmacol (2016)

Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children

le Zhang, C, Denti, P, Simonsson, USH, Maartens, G, Karlsson, MO, McIlleron, H
Foilsithe 2010

Edoxaban Exposure‐Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep‐Vein Thrombosis or Pulmonary Embolism

le Nyberg, J, Karlsson, KE, Jönsson, S, Yin, OQP, Miller, R, Karlsson, MO, Simonsson, USH
Foilsithe in CPT Pharmacometrics Syst Pharmacol (2016)

Mechanism‐Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake

le Guiastrennec, B, Sonne, DP, Hansen, M, Bagger, JI, Lund, A, Rehfeld, JF, Alskär, O, Karlsson, MO, Vilsbøll, T, Knop, FK, Bergstrand, M
Foilsithe in CPT Pharmacometrics Syst Pharmacol (2016)

Population Pharmacokinetic Model for Docetaxel in Patients with Varying Degrees of Liver Function: Incorporating Cytochrome P450 3A Activity Measurements

le Hooker, AC, ten Tije, AJ, Carducci, MA, Weber, J, Garrett-Mayer, E, Gelderblom, H, McGuire, WP, Verweij, J, Karlsson, MO, Baker, SD
Foilsithe 2008

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

le Nguyen, THT, Mouksassi, M‐S, Holford, N, Al‐Huniti, N, Freedman, I, Hooker, AC, John, J, Karlsson, MO, Mould, DR, Pérez Ruixo, JJ, Plan, EL, Savic, R, van Hasselt, JGC, Weber, B, Zhou, C, Comets, E, Mentré, F
Foilsithe in CPT Pharmacometrics Syst Pharmacol (2017)